Financial News

Financial Report: INC Research

Revenues up 13% in the quarter

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

INC Research 3Q Revenues: $391.8 million (+12%) 3Q Earnings: $27.3 million (-28%) YTD Revenues: $1.2 billion (+21%) YTD Earnings: $75.1 million (-13%) Comments: The company saw growth across all therapeutic areas, particularly in the central nervous system, oncology and other complex therapeutic areas. Restructuring charges were $2.9 million in the quarter, which included CEO transition and other costs associated with a reduction of workforce. Backlog grew 12.3% to $2.0 billion as...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters